Literature DB >> 19496939

Pathological study of pseudohypertrophy of the inferior olivary nucleus.

Katsuhiko Ogawa1, Tomohiko Mizutani, Kenji Uehara, Masayuki Minami, Yoshio Suzuki, Toshiki Uchihara.   

Abstract

There have been only a few reports about the immunohistochemical study of pseudohypertrophy of the inferior olivary nucleus (PH-IO). We therefore performed the detailed immunohistochemical study of 10 PH-IOs in 8 patients to clarify the mechanism of neuronal degeneration and its related phenomenon of PH-IO. We used various antibodies to alphaB-crystallin (alphaBC), synaptophysin (SYP), microtubule-associated protein 2 (MAP2), Lys-Asp-Glu-Leu (KDEL) receptors, heat shock protein (HSP) 27 as well as SMI-31. We found alphaBC-positive neurons on the ipsilateral side of 10 PH-IOs. SMI-31-positive neurons were also observed in 6 PH-IOs. Confocal laser microscopy showed co-localization of alphaBC and SMI-31 in some neurons. However, there were no HSP27-positive neurons or astrocytes in any of the 10 PH-IOs. MAP2 immunostaining showed MAP2-positive hypertrophic thick neurites around hypertrophic neurons on the ipsilateral side of 7 PH-IOs and demonstrated "glomeruloid structures" in 3 PH-IOs. In addition, fine granular SYP-immunoreactivity was decreased in the neuropils on the ipsilateral side of all 10 PH-IOs. SYP-immunoreactive dots were scattered in the neuropils and on the neuronal cell bodies on the side of 7 PH-IOs, and the aggregation of SYP-immunoreactive dots scattered in the neuropils was shown in 3 PH-IOs. Double-immunostainings using anti-MAP2 and anti-SYP antibodies demonstrated frequent SYP-immunoreactive dots along the MAP2-positive hypertrophic thick neurites and their cell bodies. Periphery-stained KDEL-positive neurons were also found on the side of 7 PH-IOs. We showed that the change of the distribution of presynaptic terminals correlated well to the hypertrophic thick neurites in PH-IO. Our immuohistochemical stainings demonstrated various changes which occurred to the neurons in PH-IO, and their neurites and presynaptic terminals. We considered that alphaBC was expressed in the neurons in PH-IO, induced by cellular stress. Such a detailed immunohistochemical investigation has not been reported previously.

Entities:  

Mesh:

Year:  2009        PMID: 19496939     DOI: 10.1111/j.1440-1789.2009.01033.x

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  6 in total

1.  Collision in the inferior olive: hypertrophic olivary degeneration complicated by radiation necrosis in brainstem primitive neuroendocrine tumor.

Authors:  Patricia Litkowski; Robert J Young; Suzanne L Wolden; Mark M Souweidane; Sofia Haque; Stephen W Gilheeney
Journal:  Clin Imaging       Date:  2012-06-08       Impact factor: 1.605

2.  Hypertrophic Olivary Degeneration Secondary to Neuro-Behçet's Disease.

Authors:  W A Martins; L P Schilling; F K Neto; J Becker
Journal:  Clin Neuroradiol       Date:  2015-03-24       Impact factor: 3.649

Review 3.  Hypertrophic Olivary Degeneration and Palatal or Oculopalatal Tremor.

Authors:  Caroline Tilikete; Virginie Desestret
Journal:  Front Neurol       Date:  2017-06-29       Impact factor: 4.003

Review 4.  Functional Outcomes of Cerebellar Malformations.

Authors:  Jason S Gill; Roy V Sillitoe
Journal:  Front Cell Neurosci       Date:  2019-10-04       Impact factor: 5.505

5.  Qualitative and quantitative detectability of hypertrophic olivary degeneration in T2, FLAIR, PD, and DTI: A prospective MRI study.

Authors:  Eike Steidl; Maximilian Rauch; Elke Hattingen; Stella Breuer; Jan Rüdiger Schüre; Marike Grapengeter; Manoj Shrestha; Christian Foerch; Martin A Schaller-Paule
Journal:  Front Neurol       Date:  2022-08-03       Impact factor: 4.086

Review 6.  A case of hypertrophic olivary degeneration after resection of cavernomas of the brain stem and review of the literature.

Authors:  Meng Zhang; Gengfan Ye; Lin Deng; Shuo Xu; Yunyan Wang
Journal:  Neuropsychiatr Dis Treat       Date:  2015-10-08       Impact factor: 2.570

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.